3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
2
Oropharyngeal Neoplasms
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
Pelvic Neoplasms
1
Papillary Thyroid Microcarcinoma
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Meningioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
atezolizumab
3
Specimen Handling
2
selinexor
1
pembrolizumab
1
pazopanib
1
fludarabine
1
cabozantinib
1
Zoledronic Acid
1
Radiotherapy
1
Radiation
1
Immunoglobulin G
1
Ifosfamide
1
Doxorubicin
1
Disulfides
1
Dactinomycin
1
Cyclophosphamide
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Alveolar Soft Part
×
Watchful Waiting
×
90 days
×
Clear all
No trials found.